Specific calcium antagonists in the treatment of peripheral vascular disease.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001692:Biological Transport / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002936:Cinnarizine / Q000627:therapeutic use; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D009130:Muscle, Smooth / Q000166:cytology; D010208:Papaverine / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*
D002936:Cinnarizine; D010208:Papaverine; D002118:Calcium